Nanobiomaterials
261,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Gebundenes Buch

The present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal & regulatory issues on the usage of nanobiomaterials have been assigned due consideration.

Andere Kunden interessierten sich auch für
Produktbeschreibung
The present book volume presents a holistic view of the aspects of nanobiomaterials incl. their stellar merits and limitations, applications in diverse fields, their futuristic promise in the fields of biomedical science and drug delivery. The federal & regulatory issues on the usage of nanobiomaterials have been assigned due consideration.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Acclaimed globally for his QbD-based development of novel and nanostructured drug delivery, computational pharmaceutics, advanced pharmacokinetic modelling, Professor Bhupinder Singh Bhoop has contributed over three decades of dedicated service towards Pharmaceutical Education and Research. He has to his credit over 300 publications in peer-reviewed journals including 16 books and 52 book chapters. A widely travelled scientist, he has delivered more than 290 plenary, keynote and invited talks in India and overseas, including in USA, Canada, UK, Germany, China, Thailand, Hong Kong, Kuwait and Bangladesh. He has been conferred with numerous global and national awards. Over a thousand of industrial scientists from leading pharma companies of India, of the likes of Mylan, Zydus, Ranbaxy, Cipla, Cadila Pharma, Sentiss, Sun Pharma, IPCA, Glenmark, Sanofi-Aventis, Ajanta, Alkem, Bharat Serums, Panacea Biotec and Beximco Pharma (Dhaka) have been duly trained by him on QbD and Biowaivers. He has guided/guiding 31 doctoral, 54 postgraduate, and 6 post-doctoral research projects, completed 6 industrial consultancy assignments, has 5 patents (1 granted), and is involved in tech. transfer of two nano-based drug delivery products.